(Q44013969)

English

Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus

scientific article published in June 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

type 2 diabetes

0 references

pharmacodynamics

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Menger Chung

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Ione Kourides

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

William Canovatchel

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tamara Sutfin

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Michael Messig

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Rochelle L Chaiken

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

651-657

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM.

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

A Prospective Trial of Risk Factors for Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom prospective diabetes study (UKPDS 47)

1 reference

https://api.crossref.org/works/10.1177/00970002042006007

21 January 2018

Identifiers

10.1177/00970002042006007

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44013969&oldid=2144471990"